{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:55:34Z","timestamp":1790596534280,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-01019-2","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:54:39Z","timestamp":1790315679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting biglycan\u2013TLR2\/TLR4 interaction with synthetic peptides mitigates inflammation and ameliorates renal function in ischemia\u2013reperfusion injury"],"prefix":"10.1186","volume":"31","author":[{"given":"Rosetta","family":"Merline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Tzung-Harn","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Zeng-Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Vutukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Wygrecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Bartoszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3318-3005","authenticated-orcid":false,"given":"Liliana","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"11","key":"1019_CR1","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s11255-018-1918-6","volume":"50","author":"L Gu","year":"2018","unstructured":"Gu L, Tao Y, Chen C, Ye Y, Xiong X, Sun Y. Initiation of the inflammatory response after renal ischemia\u2013reperfusion injury during renal transplantation. Int Urol Nephrol. 2018;50(11):2027\u201335.","journal-title":"Int Urol Nephrol"},{"key":"1019_CR2","doi-asserted-by":"crossref","unstructured":"Troise D, Infante B, Mercuri S, Lindholm B, Kublickiene K, Stallone G. Exploring the immunological landscape of ischemia\u2013reperfusion injury and graft rejection in kidney transplantation: shared mechanisms and insights. Cells. 2025;14(18).","DOI":"10.3390\/cells14181443"},{"issue":"1","key":"1019_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2011","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2011;12(1):7\u201311.","journal-title":"Kidney Int Suppl"},{"key":"1019_CR4","doi-asserted-by":"crossref","unstructured":"Norgard MO, Svenningsen P. Acute kidney injury by ischemia\u2013reperfusion and extracellular vesicles. Int J Mol Sci. 2023;24(20).","DOI":"10.3390\/ijms242015312"},{"key":"1019_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.matbio.2014.01.010","volume":"35","author":"K Moreth","year":"2014","unstructured":"Moreth K, Frey H, Hubo M, Zeng-Brouwers J, Nastase MV, Hsieh LT, et al. biglycan\u2013triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol. 2014;35:143\u201351.","journal-title":"Matrix Biol"},{"issue":"5","key":"1019_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00467-009-1422-4","volume":"25","author":"K Rusai","year":"2010","unstructured":"Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, Schmaderer C, et al. Toll-like receptors 2 and 4 in renal ischemia\u2013reperfusion injury. Pediatr Nephrol. 2010;25(5):853\u201360.","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"1019_CR7","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1073\/pnas.0810169106","volume":"106","author":"B Kruger","year":"2009","unstructured":"Kruger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A. 2009;106(9):3390\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1019_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep26954","volume":"6","author":"LM Zhang","year":"2016","unstructured":"Zhang LM, Liu JH, Xue CB, Li MQ, Xing S, Zhang X, et al. Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro. Sci Rep. 2016;6:26954.","journal-title":"Sci Rep"},{"issue":"2","key":"1019_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1096\/fj.11-195396","volume":"26","author":"CA Farrar","year":"2012","unstructured":"Farrar CA, Keogh B, McCormack W, O\u2019Shaughnessy A, Parker A, Reilly M, et al. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J. 2012;26(2):799\u2013807.","journal-title":"FASEB J"},{"key":"1019_CR10","doi-asserted-by":"crossref","unstructured":"Jung SW, Seo JW, Park SH, Kim YG, Moon JY, Choi S, et al. A cell-penetrating peptide that blocks toll-like receptor signaling protects kidneys against ischemia-reperfusion injury. Int J Mol Sci. 2021;22(4).","DOI":"10.3390\/ijms22041627"},{"issue":"8","key":"1019_CR11","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1016\/S0021-9258(18)83781-4","volume":"264","author":"LW Fisher","year":"1989","unstructured":"Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem. 1989;264(8):4571\u20136.","journal-title":"J Biol Chem"},{"issue":"3-4","key":"1019_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12079-009-0066-2","volume":"3","author":"R Merline","year":"2009","unstructured":"Merline R, Schaefer RM, Schaefer L. The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal. 2009;3(3\u20134):323\u201335.","journal-title":"J Cell Commun Signal"},{"key":"1019_CR13","first-page":"150","volume":"100\u2013101","author":"M Schulz","year":"2021","unstructured":"Schulz M, Diehl V, Trebicka J, Wygrecka M, Schaefer L. Biglycan: A regulator of hepatorenal inflammation and autophagy. Matrix Biol. 2021;100\u2013101:150\u201361.","journal-title":"Matrix Biol"},{"issue":"15","key":"1019_CR14","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1111\/febs.14791","volume":"286","author":"H Roedig","year":"2019","unstructured":"Roedig H, Nastase MV, Wygrecka M, Schaefer L. Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy. FEBS J. 2019;286(15):2965\u201379.","journal-title":"FEBS J"},{"issue":"4","key":"1019_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1369\/0022155417738752","volume":"66","author":"MV Nastase","year":"2018","unstructured":"Nastase MV, Janicova A, Roedig H, Hsieh LT, Wygrecka M, Schaefer L. Small leucine-rich proteoglycans in renal inflammation: two sides of the coin. J Histochem Cytochem. 2018;66(4):261\u201372.","journal-title":"J Histochem Cytochem"},{"issue":"12","key":"1019_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1369\/0022155420930303","volume":"68","author":"J Zeng-Brouwers","year":"2020","unstructured":"Zeng-Brouwers J, Pandey S, Trebicka J, Wygrecka M, Schaefer L. Communications via the small leucine-rich proteoglycans: molecular specificity in inflammation and autoimmune diseases. J Histochem Cytochem. 2020;68(12):887\u2013906.","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"1019_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1369\/0022155417740880","volume":"66","author":"CW Frevert","year":"2018","unstructured":"Frevert CW, Felgenhauer J, Wygrecka M, Nastase MV, Schaefer L. Danger-associated molecular patterns derived from the extracellular matrix provide temporal control of innate immunity. J Histochem Cytochem. 2018;66(4):213\u201327.","journal-title":"J Histochem Cytochem"},{"issue":"15","key":"1019_CR18","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1111\/febs.17107","volume":"291","author":"S Ricard-Blum","year":"2024","unstructured":"Ricard-Blum S, Vives RR, Schaefer L, Gotte M, Merline R, Passi A, et al. A biological guide to glycosaminoglycans: current perspectives and pending questions. FEBS J. 2024;291(15):3331\u201366.","journal-title":"FEBS J"},{"issue":"8","key":"1019_CR19","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1172\/JCI23755","volume":"115","author":"L Schaefer","year":"2005","unstructured":"Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest. 2005;115(8):2223\u201333.","journal-title":"J Clin Invest"},{"key":"1019_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.matbio.2013.12.003","volume":"35","author":"J Zeng-Brouwers","year":"2014","unstructured":"Zeng-Brouwers J, Beckmann J, Nastase MV, Iozzo RV, Schaefer L. De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88\/TRIF pathways. Matrix Biol. 2014;35:132\u201342.","journal-title":"Matrix Biol"},{"issue":"12","key":"1019_CR21","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1172\/JCI42213","volume":"120","author":"K Moreth","year":"2010","unstructured":"Moreth K, Brodbeck R, Babelova A, Gretz N, Spieker T, Zeng-Brouwers J, et al. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest. 2010;120(12):4251\u201372.","journal-title":"J Clin Invest"},{"key":"1019_CR22","doi-asserted-by":"crossref","unstructured":"Hsieh LT, Nastase MV, Roedig H, Zeng-Brouwers J, Poluzzi C, Schwalm S, et al. biglycan\u2013 and sphingosine kinase-1 signaling crosstalk regulates the synthesis of macrophage chemoattractants. Int J Mol Sci. 2017;18(3).","DOI":"10.3390\/ijms18030595"},{"key":"1019_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.matbio.2017.12.002","volume":"68-69","author":"MV Nastase","year":"2018","unstructured":"Nastase MV, Zeng-Brouwers J, Beckmann J, Tredup C, Christen U, Radeke HH, et al. Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol. 2018;68\u201369:293\u2013317.","journal-title":"Matrix Biol"},{"key":"1019_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.matbio.2018.05.006","volume":"77","author":"H Roedig","year":"2019","unstructured":"Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C, et al. Biglycan is a new high-affinity ligand for CD14 in macrophages. Matrix Biol. 2019;77:4\u201322.","journal-title":"Matrix Biol"},{"issue":"3","key":"1019_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.kint.2018.10.037","volume":"95","author":"C Poluzzi","year":"2019","unstructured":"Poluzzi C, Nastase MV, Zeng-Brouwers J, Roedig H, Hsieh LT, Michaelis JB, et al. Biglycan evokes autophagy in macrophages via a novel CD44\/Toll-like receptor 4 signaling axis in ischemia\u2013reperfusion injury. Kidney Int. 2019;95(3):540\u201362.","journal-title":"Kidney Int"},{"key":"1019_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biocel.2014.07.020","volume":"54","author":"LT Hsieh","year":"2014","unstructured":"Hsieh LT, Nastase MV, Zeng-Brouwers J, Iozzo RV, Schaefer L. Soluble biglycan as a biomarker of inflammatory renal diseases. Int J Biochem Cell Biol. 2014;54:223\u201335.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"1019_CR27","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.ajpath.2011.05.016","volume":"179","author":"J Thompson","year":"2011","unstructured":"Thompson J, Wilson P, Brandewie K, Taneja D, Schaefer L, Mitchell B, et al. Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol. 2011;179(3):1179\u201387.","journal-title":"Am J Pathol"},{"issue":"1-2","key":"1019_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1242\/dmm.003533","volume":"3","author":"S Wang","year":"2010","unstructured":"Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S, et al. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech. 2010;3(1\u20132):92\u2013103.","journal-title":"Dis Model Mech"},{"issue":"W1","key":"1019_CR29","doi-asserted-by":"publisher","first-page":"W276","DOI":"10.1093\/nar\/gkac240","volume":"50","author":"F Madeira","year":"2022","unstructured":"Madeira F, Pearce M, Tivey ARN, Basutkar P, Lee J, Edbali O, et al. Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res. 2022;50(W1):W276\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1019_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.matbio.2015.12.005","volume":"49","author":"LT Hsieh","year":"2016","unstructured":"Hsieh LT, Frey H, Nastase MV, Tredup C, Hoffmann A, Poluzzi C, et al. Bimodal role of NADPH oxidases in the regulation of biglycan\u2013triggered IL-1beta synthesis. Matrix Biol. 2016;49:61\u201381.","journal-title":"Matrix Biol"},{"issue":"7","key":"1019_CR31","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1681\/ASN.2010050570","volume":"22","author":"L Schaefer","year":"2011","unstructured":"Schaefer L. Small leucine-rich proteoglycans in kidney disease. J Am Soc Nephrol. 2011;22(7):1200\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"1019_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126680","author":"T Nakamura","year":"2022","unstructured":"Nakamura T, Bonnard B, Palacios-Ramirez R, Fernandez-Celis A, Jaisser F, Lopez-Andres N. Biglycan is a novel mineralocorticoid receptor target involved in aldosterone\/salt-induced glomerular injury. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23126680.","journal-title":"Int J Mol Sci"},{"issue":"36","key":"1019_CR33","doi-asserted-by":"publisher","first-page":"24035","DOI":"10.1074\/jbc.M109.014266","volume":"284","author":"A Babelova","year":"2009","unstructured":"Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem. 2009;284(36):24035\u201348.","journal-title":"J Biol Chem"},{"key":"1019_CR34","doi-asserted-by":"crossref","unstructured":"Mertowski S, Lipa P, Morawska I, Niedzwiedzka-Rystwej P, Bebnowska D, Hrynkiewicz R, et al. Toll-like receptor as a potential biomarker in renal diseases. Int J Mol Sci. 2020;21(18).","DOI":"10.3390\/ijms21186712"},{"issue":"2","key":"1019_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s40620-021-01153-4","volume":"35","author":"V Sepe","year":"2022","unstructured":"Sepe V, Libetta C, Gregorini M, Rampino T. The innate immune system in human kidney inflammaging. J Nephrol. 2022;35(2):381\u201395.","journal-title":"J Nephrol"},{"issue":"1","key":"1019_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000511947","volume":"7","author":"M Liu","year":"2021","unstructured":"Liu M, Zen K. Toll-like receptors regulate the development and progression of renal diseases. Kidney Dis (Basel). 2021;7(1):14\u201323.","journal-title":"Kidney Dis (Basel)"},{"issue":"34","key":"1019_CR37","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.2174\/0929867325666190603110907","volume":"27","author":"Q Ren","year":"2020","unstructured":"Ren Q, Cheng L, Yi J, Ma L, Pan J, Gou SJ, et al. Toll-like receptors as potential therapeutic targets in kidney diseases. Curr Med Chem. 2020;27(34):5829\u201354.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1019_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1753425919844310","volume":"26","author":"VY Toshchakov","year":"2020","unstructured":"Toshchakov VY, Javmen A. Targeting the TLR signalosome with TIR domain-derived cell-permeable decoy peptides: the current state and perspectives. Innate Immun. 2020;26(1):35\u201347.","journal-title":"Innate Immun"},{"key":"1019_CR39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200394","author":"A Javmen","year":"2023","unstructured":"Javmen A, Zou J, Nallar SC, Szmacinski H, Lakowicz JR, Gewirtz AT, et al. TLR5-derived, TIR-interacting decoy peptides to inhibit TLR signaling. J Immunol. 2023. https:\/\/doi.org\/10.4049\/jimmunol.2200394.","journal-title":"J Immunol"},{"issue":"4","key":"1019_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0244-0","volume":"51","author":"HK Kwon","year":"2019","unstructured":"Kwon HK, Patra MC, Shin HJ, Gui X, Achek A, Panneerselvam S, et al. A cell-penetrating peptide blocks Toll-like receptor-mediated downstream signaling and ameliorates autoimmune and inflammatory diseases in mice. Exp Mol Med. 2019;51(4):1\u201319.","journal-title":"Exp Mol Med"},{"issue":"12","key":"1019_CR41","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.celrep.2015.05.035","volume":"11","author":"W Piao","year":"2015","unstructured":"Piao W, Shirey KA, Ru LW, Lai W, Szmacinski H, Snyder GA, et al. A decoy peptide that disrupts TIRAP recruitment to TLRs is protective in a murine model of influenza. Cell Rep. 2015;11(12):1941\u201352.","journal-title":"Cell Rep"},{"issue":"6","key":"1019_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2471\/BLT.17.206441","volume":"96","author":"VA Luyckx","year":"2018","unstructured":"Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414\u201322.","journal-title":"Bull World Health Organ"},{"issue":"4","key":"1019_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.23876\/j.krcp.19.062","volume":"38","author":"SJ Han","year":"2019","unstructured":"Han SJ, Lee HT. Mechanisms and therapeutic targets of ischemic acute kidney injury. Kidney Res Clin Pract. 2019;38(4):427\u201340.","journal-title":"Kidney Res Clin Pract"},{"issue":"5","key":"1019_CR44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1681\/ASN.2013050528","volume":"25","author":"OP Kulkarni","year":"2014","unstructured":"Kulkarni OP, Hartter I, Mulay SR, Hagemann J, Darisipudi MN, Kumar Vr S, et al. Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J Am Soc Nephrol. 2014;25(5):978\u201389.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1019_CR45","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/TP.0000000000000358","volume":"98","author":"K Miura","year":"2014","unstructured":"Miura K, Sahara H, Sekijima M, Kawai A, Waki S, Nishimura H, et al. Protective effect of neutralization of the extracellular high-mobility group box 1 on renal ischemia-reperfusion injury in miniature swine. Transplantation. 2014;98(9):937\u201343.","journal-title":"Transplantation"},{"issue":"8","key":"1019_CR46","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1681\/ASN.2011111077","volume":"23","author":"R Allam","year":"2012","unstructured":"Allam R, Scherbaum CR, Darisipudi MN, Mulay SR, Hagele H, Lichtnekert J, et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol. 2012;23(8):1375\u201388.","journal-title":"J Am Soc Nephrol"},{"key":"1019_CR47","doi-asserted-by":"crossref","unstructured":"Godoy JR, Watson G, Raspante C, Illanes O. An effective mouse model of unilateral renal ischemia-reperfusion injury. J Vis Exp. 2021(173).","DOI":"10.3791\/62749-v"},{"issue":"4","key":"1019_CR48","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1159\/000489241","volume":"46","author":"MY Wu","year":"2018","unstructured":"Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650\u201367.","journal-title":"Cell Physiol Biochem"},{"key":"1019_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1119368","volume":"14","author":"R Shainer","year":"2023","unstructured":"Shainer R, Kram V, Kilts TM, Li L, Doyle AD, Shainer I, et al. Biglycan regulates bone development and regeneration. Front Physiol. 2023;14:1119368.","journal-title":"Front Physiol"},{"key":"1019_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27104380","author":"WT Li","year":"2026","unstructured":"Li WT, Yu JK, Cui GQ. Biglycan reconstitutes a neonatal ECM signaling microenvironment to drive stem cell-mediated tendon regeneration via a scaffold-free cell sheet platform. Int J Mol Sci. 2026. https:\/\/doi.org\/10.3390\/ijms27104380.","journal-title":"Int J Mol Sci"}],"container-title":["Cellular & Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-01019-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-01019-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-01019-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:01:01Z","timestamp":1790593261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-01019-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-01019-2","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed in accordance with the German Animal Protection Law and were approved by The Ethics Review Committee for Laboratory Animals of the District Government of Darmstadt, Germany (Approval No: FU\/1063, 16.07.2015\u201315.07.2020), the local ethics committees act on International Council for Laboratory Animal Science (ICLAS).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"151"}}